Evidence map›Paper›PMID 42006443›Full record

ArticleAmerican journal of preventive cardiology2026

Associations of 10-year predicted ASCVD risk by the PREVENT equations with AI-analyzed coronary atherosclerotic plaque characteristics.

Chen Gurevitz, Rebecca Fisher, Paul Muntner, Tyler Sagendorf, Edward A Fisher, Robert S Rosenson

Abstract read
In one paragraph

Article in American journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chen GurevitzMetabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, NY, NY, USA.
Rebecca FisherMount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, NY, NY, USA.
Paul MuntnerDepartment of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, USA.
Tyler SagendorfPerisphere Real World Evidence, LLC, Austin, TX, USA.
Edward A FisherMount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, NY, NY, USA.
Robert S RosensonMetabolism and Lipids Program, Mount Sinai Fuster Heart Hospital, NY, NY, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The PREVENT equations estimate 10-year atherosclerotic cardiovascular disease (ASCVD) risk. If 10-year ASCVD risk is associated with coronary plaque burden, it can guide who should be screened. Methods: Asymptomatic patients without prior cardiovascular events underwent coronary CT angiography, with plaque features quantified using AI-based analysis. Ten-year predicted ASCVD risk was calculated by the PREVENT equations and categorized as low (<5%), borderline (5-<7.5%), and intermediate-high (≥7.5%). We used quantile regression to assess associations between 10-year predicted ASCVD risk and total plaque volume (TPV), percent atheroma volume (PAV), calcified plaque (CP), non-calcified plaque (NCP), and low-density non-calcified plaque (LDNCP). Results: Overall, 425 adults, median age 55 years; 31.5% female, were included. Higher 10-year ASCVD risk was associated with more TPV, PAV, NCP, LDNCP, CP, stenosis area and diameter, and remodeling index. For example, median TPV was 63.4, 109.0, and 212.7 mm Conclusion: Ten-year ASCVD risk estimated by the PREVENT equations was associated with coronary plaque burden.

Indexed as

ASCVD-risk estimationCoronary CTAPlaque analysisPREVENT equations

Identifiers

PMID42006443
PMCPMC13084116

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.